Michelle Davis

ORCID: 0000-0002-6925-9139 · 3 papers in corpus
2024
Successful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report.
Gynecologic oncology reports ·doi:10.1016/j.gore.2024.101322

•Ovarian carcinosarcoma is a rare ovarian cancer histology that has limited treatment options.•In this study, we present an unusual association between carcinosarcoma and a STIC lesion.•In select patients with carcinosarcoma, PARP inhibitio…

article 2016
Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery?
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.05.036

ObjectiveTo describe the clinical characteristics of patients with endosalpingiosis (ES) and examine its association with endometriosis and gynecologic malignancies.MethodsWe queried the medical record for patients who underwent gynecologic…

review 2014
Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary
Gynecologic Oncology ·doi:10.1016/j.ygyno.2014.01.012

ObjectiveThe aim of this investigation was to compare outcomes of patients with clear cell carcinoma (CCC) and endometrioid carcinoma (EC) of the ovary associated with endometriosis to patients with ovarian papillary serous carcinoma (PSC).…